InvestorsHub Logo
Followers 78
Posts 11422
Boards Moderated 0
Alias Born 04/03/2014

Re: None

Monday, 10/14/2019 8:11:26 PM

Monday, October 14, 2019 8:11:26 PM

Post# of 3836
Here are NASH-CX trial protocol guidelines for P3 - there were written in Jun 2019 as if specifically for GALT.
Not sure anyone is close to P3.

One can see that the inclusion - exclusion
Criteria are stringent - enrollment will be expensive and long process.

https://www.fda.gov/media/127738/download
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GALT News